Skip to main content
OpenTrials
Completed

NCT Number: NCT04759976

Optimize Motor Learning to Improve Neurorehabilitation

The objective of this study is to develop and evaluate novel robotic training strategies that modulate errors based on the subjects' individual motor and cognitive needs. For this purpose, healthy adults and neurologic patients will participate in robotic motor learning experiments. Patients have a diagnosis of a neurological disease (i.e., stroke, spinal cord injury, multiple sclerosis, Guillain-Barré syndrome) limiting arm motor function.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Bern

Bern, 3010, Switzerland

About this study

Neurological patients (e.g., after stroke) engage in intensive and expensive neurorehabilitation therapy to regain part of their former motor functional ability to perform everyday activities with often limited and unsatisfactory outcome. Robots became a promising supplement or even alternative for neurorehabilitation therapy, providing cost-effective, high repetition and task-oriented training. However, results of an initial body of work comparing the effectiveness of robotic training strategies are highly inconclusive. A possible explanation is that most current robotic systems cover only one neurorehabilitation strategy (e.g. reducing or augmenting movement errors) and may thus insufficiently address the subjects' individual needs and the characteristics of the task to be learned. In this study, Investigators will perform several motor learning experiments with healthy adult and neurological patients in order to evaluate the relative motor and cognitive benefits of newly developed robotic training strategies that modulate errors based on the subject's age, skill level and tasks characteristics. The effects of the new strategies will be compared to classical robotic assistance, and to non-robotic feedback approaches, such as visual feedback. The culmination of this work may help to optimize training benefits of already existing rehabilitation robots.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged ≥18 years
  • Informed Consent as documented by signature ("Informed Consent" form)
  • Bodyweight <120 kg
  • Ability to communicate effectively with the examiner so that the validity of the patient's data could not be compromised

Exclusion criteria

  • Excessive spasticity of the affected arm (Ashworth Scale ≥3)
  • Serious medical or psychiatric disorder
  • Orthopaedic, rheumatological, or other disease restricting movements of the paretic arm
  • Shoulder subluxation
  • Skin ulcerations at the paretic arm
  • Cyber-sickness (i.e., nausea when looking at a screen or playing computer games)
  • Serious cognitive defects or aphasia preventing effective use of the robotic devices
  • Severe visual and auditory impairments

Treatment and study plan

Robotic motor training

Behavioral

The experiments consist in performing motor tasks with upper-limb robotic devices.

Primary outcomes

  1. Change in kinematic performance assessed by the robot

    Time frame: Baseline, training (immediately after baseline), retention (1-2 days after the training)

    Motion changes from baseline in the kinematic variables assessed by the robot and motion trackers during the motor learning task. The kinematic performance analysis consists of end-effector position in the x, y, and z-axis, in meters, and joint angles in degrees.

  2. Change in kinetic performance assessed by the robot

    Time frame: Baseline, training (immediately after baseline), retention (1-2 days after the training)

    Force changes from baseline in the kinetic variables assessed by the robot using force sensors during the motor learning task. Kinetic performance analysis consists of interaction forces in x, y, and z-axis, in N and applied robot joint torques by the motors, in Nm.

  3. Spatial analysis of changes in evoked potentials as assessed by Electroencephalography (EEG) measurement

    Time frame: Baseline, training (immediately after baseline), retention (1-2 days after the training)

    Electroencephalographical assessment of changes in evoked potentials i.e. the electrical activity of the brain in response to stimulation of specific sensory nerve pathways.

Secondary outcomes

  1. Change in embodiment

    Time frame: Before Intervention, Immediately after the end of intervention

    Virtual Reality (VR) Embodiment Scale, Self administered Likert scale of 1-7 (Strongly Disagree to Strongly Agree)

  2. Spatial analysis of changes in Task-Based Brain Connectivity as assessed by Electroencephalography (EEG) measurement

    Time frame: Baseline, training (immediately after baseline or 1-2 days after baseline), retention (1-2 days after the training)

    Changes in Task-Based Brain Connectivity from baseline in electroencephalography measurement

  3. Change in Motivation as assessed by Intrinsic Motivation Inventory (IMI)

    Time frame: Before Intervention, Immediately after the end of intervention, at the end of the session

    Intrinsic Motivation Inventory, Self administered. Likert scale of 1-7 (1: not at all true - 4: somewhat true - 7: very true)

  4. Change in Cognitive Load as assessed by National Aeronautics and Space Administration (NASA) (Raw) Task Load Index

    Time frame: Immediately after the end of intervention, At the end of the session

    Self-reported cognitive load during a task, Self-administered National Aeronautics and Space Administration (Raw) Task Load Index (TLX), analog scale mapped from 0 to 100 (Endpoints: Low/High, Good/Poor)

  5. System Usability as assessed by System Usability Scale (SUS)

    Time frame: Immediately after the end of intervention, At the end of the session

    Self reported system usability assessed by System Usability Scale (SUS) Likert scale of 1-5 (Strongly agree to Strongly disagree)

Sponsors and collaborators

Lead sponsor

University of Bern

Other

Registry information

Acronym: OnLINE

Important dates

Study start
2019
Primary completion
2024
Study completion
2024
First posted
Feb 18, 2021
Registry last updated
Sep 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.